Why the study?
Does intravenous dexmedetomidine infusion reduce stress response markers (IL-6 and cortisol) in patients undergoing elective open heart surgery with CPB?
Does intravenous dexmedetomidine infusion reduce stress response markers (IL-6 and cortisol) in patients undergoing elective open heart surgery with CPB?
Intravenous dexmedetomidine during open heart surgery with CPB safely suppresses inflammatory and stress responses while stabilizing hemodynamics.
Answers are grounded in this paper and cite their sources.
Supports dexmedetomidine to blunt stress markers in CPB surgery; confirms anti-inflammatory effects in RCT.
Aim of the work: to evaluate the effect of intravenous dexmedetomidine infusion on patientsundergoing open heart surgery regarding stress response markers as plasma interleukin-6 andplasma cortisol.Patents and Methods: Fifty consecutive patients aged 18-70years, scheduled for elective openheart surgery using CPB technique were enrolled in this study at the Cardiothoracic Surgery Unit,Luxor international hospital, from July 2018 to May 2019. Patients randomly assigned using closedenvelope technique into two equal groups according to the drug infused intraoperatively: 1st group < br />(25 patients):- Dexmedetomidine group (Group D); received loading dose of intravenousdexmedetomidine infusion of 1 μg/kg IV dissolved in 20ml normal saline over 10 minutes followedby maintenance dose of 0.5 μg/kg/hr. till the end of surgery where 0.5 μg /kg/h was calculated foreach patient and dissolved in 12.5 ml normal saline 2nd group ( 25 patients):- placebo group (Group < br />P); receive 20ml intravenous infusion of normal saline 0.9 % over 10 minutes followed bycontinuous infusion of 12.5 ml of normal saline till the end of surgery.Results: Our study revealed that HR and MAP wasn’t significantly different between the twogroups at the baseline, but significantly lowered in Dex. group after induction, during CPB, postCPB, and postoperative.Dexometomedine suppress the intraoperative and postoperative rise of IL-6which was significantly higher in placebo group relative to Dex. group. Also dexometomedine haseffect on stress hormone as serum cortisol and serum glucose decease in Dex. group relative toplacebo group. None of studied cases revealed bradycardia or hypotention and there are nosignificant difference between groups regarding side effect drowsiness, nausea and vomitingConclusion: This study demonstrated that the continuous administration of dexmedetomidineduring open heart surgery with CPB suppressed intraoperative and post-operative cytokinesecretion, and improved post-operative inflammatory response indices in the present study. Also itstabilize blood pressure and heart rate and blunt cardiovascular response to CPB. These resultscould be attributed to the anti-inflammatory effects of dexmedetomidine.
No takes yet. Share an insight, caveat, or question.
Youssef et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: